Suppr超能文献

Hero导管在患有上腔静脉阻塞的依赖导管透析患者中的应用。

The use of HeRo catheter in catheter-dependent dialysis patients with superior vena cava occlusion.

作者信息

Davis Kathryn L, Gurley John C, Davenport Daniel L, Xenos Eleftherios S

机构信息

Department of Surgery, University of Kentucky, Lexington, Kentucky - USA.

出版信息

J Vasc Access. 2016 Mar-Apr;17(2):138-42. doi: 10.5301/jva.5000493. Epub 2016 Jan 20.

Abstract

OBJECTIVES

Hemodialysis (HD) patients with superior vena cava (SVC) occlusion have limited access options. Femoral access is commonly employed but is associated with high complication rates. Hemodialysis Reliable Outflow (HeRO) catheters can be used in tunneled catheter-dependent (TCD) patients who have exhausted other access options. The HeRO graft bypasses occlusion and traverses stenosis with outflow directly into the central venous circulation. At our institution we have used the inside-out central venous access technique (IOCVA) to traverse an occluded vena cava for HeRO graft placement. We review our experience with this technique.

METHODS

A retrospective chart review was conducted of patients with HeRO graft placement at our institution. All were dependent on a tunneled femoral dialysis catheter due to central venous occlusion (CVO). The IOCVA technique was used in each case. This technique was used as last resort for patients who had no other dialysis access option. Demographics, patency rates, complications, and mortality were recorded.

RESULTS

A total of 11 HeRO grafts were placed in 11 patients from January 2012 to June 2013, with 100% technical success rate. Three grafts were ligated due to steal syndrome. Two grafts were lost due to thrombosis. Five of 11 patients experienced a 30-day complication. Three patients died within the follow-up period; however, none were directly related to the graft placement. Follow up range was 65-573 days; 5 of 11 grafts were used for dialysis at the end of the follow-up period. The 12-month patency rate was 30%.

CONCLUSIONS

HeRO grafts are one option for dialysis patients with CVO. There is, however, a high incidence of steal syndrome and other complications. These grafts should be offered as a final potential alternative to catheter dependence.

摘要

目的

患有上腔静脉(SVC)闭塞的血液透析(HD)患者的血管通路选择有限。股静脉通路是常用的,但并发症发生率高。血液透析可靠流出(HeRO)导管可用于其他血管通路选择已用尽的长期依赖隧道式导管(TCD)的患者。HeRO移植物可绕过闭塞部位并穿过狭窄部位,其流出端直接进入中心静脉循环。在我们机构,我们采用由内向外的中心静脉通路技术(IOCVA)穿过闭塞的腔静脉来放置HeRO移植物。我们回顾了我们使用该技术的经验。

方法

对在我们机构接受HeRO移植物植入的患者进行回顾性病历审查。所有患者均因中心静脉闭塞(CVO)而依赖隧道式股静脉透析导管。每例均采用IOCVA技术。该技术用于没有其他透析血管通路选择的患者作为最后手段。记录患者的人口统计学资料、通畅率、并发症和死亡率。

结果

2012年1月至2013年6月,11例患者共植入11个HeRO移植物,技术成功率达100%。3个移植物因窃血综合征而结扎。2个移植物因血栓形成而失功。11例患者中有5例发生了30天内的并发症。3例患者在随访期内死亡;然而,均与移植物植入无直接关系。随访时间为65 - 573天;随访期末,11个移植物中有5个用于透析。12个月的通畅率为30%。

结论

HeRO移植物是患有CVO的透析患者的一种选择。然而,窃血综合征和其他并发症的发生率很高。这些移植物应作为导管依赖的最终潜在替代方案提供给患者。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验